There is evidence showing that the changes at miRNA levels are associated with some parts of AD pathology, such as in the case of miR-16 which could potentially inhibit expression of amyloid precursor protein (APP) in age-related senescence-accelerated mouse prone 8 (SAMP8) mice [32]. The gene discussed is APP; the disease is Alzheimer disease.